These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36286707)

  • 21. Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response.
    Mauri MC; Volonteri LS; Colasanti A; Fiorentini A; De Gaspari IF; Bareggi SR
    Clin Pharmacokinet; 2007; 46(5):359-88. PubMed ID: 17465637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comedication of Valproic Acid Is Associated With Increased Metabolism of Clozapine.
    Hommers L; Scharl M; Hefner G; Hohner M; Fischer M; Pfuhlmann B; Deckert J; Unterecker S
    J Clin Psychopharmacol; 2018 Jun; 38(3):188-192. PubMed ID: 29620699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma linoelaidyl carnitine levels positively correlated with symptom improvement in olanzapine-treated first-episode drug-naïve schizophrenia.
    Wang X; Xiu M; Wang K; Su X; Li X; Wu F
    Metabolomics; 2022 Jul; 18(7):50. PubMed ID: 35819637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
    Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Nomura I; Hatano M; Iwata N
    Mol Psychiatry; 2022 Feb; 27(2):1136-1144. PubMed ID: 34642461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.
    McEvoy JP; Lieberman JA; Stroup TS; Davis SM; Meltzer HY; Rosenheck RA; Swartz MS; Perkins DO; Keefe RS; Davis CE; Severe J; Hsiao JK;
    Am J Psychiatry; 2006 Apr; 163(4):600-10. PubMed ID: 16585434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic drug monitoring of atypical antipsychotics.
    Urban AE; Cubała WJ
    Psychiatr Pol; 2017 Dec; 51(6):1059-1077. PubMed ID: 29432503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia.
    An H; Fan H; Yun Y; Chen S; Qi S; Ma B; Shi J; Wang Z; Yang F
    Front Psychiatry; 2022; 13():930457. PubMed ID: 35800023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
    Markianos M; Hatzimanolis J; Lykouras L
    Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):141-6. PubMed ID: 11697576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bipolar Disorder and Outcomes of Monotherapy with Lithium, Valproate, Quetiapine, Olanzapine, Venlafaxine, and Citalopram.
    Bohlken J; Riedel-Heller S; Bauer M; Kostev K
    Pharmacopsychiatry; 2021 May; 54(3):126-130. PubMed ID: 33494115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
    Rummel-Kluge C; Komossa K; Schwarz S; Hunger H; Schmid F; Lobos CA; Kissling W; Davis JM; Leucht S
    Schizophr Res; 2010 Nov; 123(2-3):225-33. PubMed ID: 20692814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia.
    David SR; Taylor CC; Kinon BJ; Breier A
    Clin Ther; 2000 Sep; 22(9):1085-96. PubMed ID: 11048906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication.
    Gex-Fabry M; Balant-Gorgia AE; Balant LP
    Ther Drug Monit; 2003 Feb; 25(1):46-53. PubMed ID: 12548144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of prohibiting outside food during COVID-19 pandemic on the body weight of schizophrenic patients taking olanzapine or clozapine: a retrospective self-controlled study.
    Zhang C; Wang X; Hu C; Ding W; Li H; Wu M; Hu M; Wang Q; Sun X
    Ann Palliat Med; 2021 May; 10(5):5010-5016. PubMed ID: 33894724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of adjunctive lamotrigine treatment on the plasma concentrations of clozapine, risperidone and olanzapine in patients with schizophrenia or bipolar disorder.
    Spina E; D'Arrigo C; Migliardi G; Santoro V; Muscatello MR; Micò U; D'Amico G; Perucca E
    Ther Drug Monit; 2006 Oct; 28(5):599-602. PubMed ID: 17038872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of smoking cigarettes, age, and sex with serum concentrations of olanzapine in patients with schizophrenia.
    Horvat M; Kadija M; Ščavničar A; Živković M; Šagud M; Lovrić M
    Biochem Med (Zagreb); 2023 Oct; 33(3):030702. PubMed ID: 37841771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effects of asenapine or olanzapine in patients with persistent negative symptoms of schizophrenia: a pooled analysis.
    Potkin SG; Phiri P; Szegedi A; Zhao J; Alphs L; Cazorla P
    Schizophr Res; 2013 Nov; 150(2-3):442-9. PubMed ID: 24075603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Haloperidol and Olanzapine on Hippocampal Cells' Proliferation in Animal Model of Schizophrenia.
    Osacka J; Kiss A; Bacova Z; Tillinger A
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age and gender effects on olanzapine and risperidone plasma concentrations in children and adolescents.
    Aichhorn W; Marksteiner J; Walch T; Zernig G; Hinterhuber H; Stuppaeck C; Kemmler G
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):665-74. PubMed ID: 17979586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.